← FDA DRUG APPROVALS

FDA ANDA · ANDA077067

NIMODIPINE

Sponsor: SUN PHARM INDS INC

APPLICATION
ANDA077067
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-17
LATEST ACTION
2012-01-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

NIMODIPINEDiscontinued
NIMODIPINE 30MG · CAPSULE · ORAL

Approval history

2012-01-18Labeling · Supplement 14AP
2010-03-30Labeling · Supplement 11AP
2007-04-17OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →